Gradalis Growth, Revenue, Number of Employees and Funding

Overview

Location:
Dallas, TX USA
Total Funding:$40M
Industry:Biotech
Founded:2003
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Gradalis's estimated revenue is currently $6.2M per year.
  • Gradalis's estimated revenue per employee is $144186
  • Gradalis's total funding is $40M.

Employee Data

  • Gradalis has 43 Employees.
  • Gradalis grew their employee count by 43% last year.
  • Gradalis currently has 1 job openings.

Executive Contacts

NameTitle
Luisa ManningVice President - Medical and Scientific Affairs
Ernest BognarChief Operating Officer
Ruth ChavezExecutive Assistant to President/CEO at Gradalis, Inc.
John NemunaitisChief Medical Officer
Gladice WallravenVice President, Clinical and Regulatory Operations
Walter ChenVice President - Finance & Corporate Development

What Is Gradalis?

We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil®, our proprietary immunotherapy platform in multiple advanced cancer indications.

keywords:N/A

43

Number of Employees

$6.2M

Revenue (est)

1

Current Jobs

43%

Employee Growth %

$40M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Bellicum Pharma...
$1.1M148-11%N/A
G-CON Manufactu...
$8.8M6133%N/A
BioNews Service...
$8.7M6011%N/A
Luminex Corpora...
$158.4M109410%N/A
Family Tree DNA
$5.7M4018%N/A
XBiotech USA
$10.9M7512%N/A
Celling Bioscie...
$9M62-2%N/A
Gradalis
$6.2M4343%N/A
Myriad RBM
$16.7M1167%N/A
Selleck Chemica...
$22M1528%N/A

Gradalis News

09/09/2019 - Global RNA Drugs Market 2019-2025 Calimmune, Dicerna ...

Global RNA Drugs Market 2019-2025 is a comprehensive report which provides a detailed overview of the major driver, opportunities, ...

03/04/2019 - Gradalis Announces Medical Leadership Team Promotion

DALLAS, March 04, 2019 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational ...

09/06/2019 - RNAi Technology Market Research Report Analysis And ...

Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics, among others, hold the substantial market ...